These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17537362)

  • 1. The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis.
    Gutiérrez Tous MR; Couto Caro C; García-Donas Gabaldón G; Viloria Peñas Mdel M; Simón Pilo I; Almeida González C
    Med Clin (Barc); 2007 May; 128(17):652-4. PubMed ID: 17537362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.
    Eroglu A; Ulu A; Cam R; Kurtman C; Akar N
    J Thromb Thrombolysis; 2007 Feb; 23(1):31-4. PubMed ID: 17106650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
    Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
    Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.
    Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E
    Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
    Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.
    Lichy C; Dong-Si T; Reuner K; Genius J; Rickmann H; Hampe T; Dolan T; Stoll F; Grau A
    J Neurol; 2006 Mar; 253(3):316-20. PubMed ID: 16155788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.
    Gurgey A; Haznedaroglu IC; Egesel T; Buyukasik Y; Ozcebe OI; Sayinalp N; Dundar SV; Bayraktar Y
    Am J Hematol; 2001 Jun; 67(2):107-11. PubMed ID: 11343382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
    Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.
    Ridker PM; Hennekens CH; Miletich JP
    Circulation; 1999 Mar; 99(8):999-1004. PubMed ID: 10051291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
    Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci PM; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci PG; Biffi R; Orsi F; Cinieri S; Goldhirsch A
    Ann Oncol; 2004 Apr; 15(4):590-3. PubMed ID: 15033664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.